LAS VEGAS, NV / ACCESS Newswire / June 11, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing in ...

An analyst launched coverage of the biotech stock. An analyst's downbeat new take on Summit Therapeutics (NASDAQ: SMMT) ...

Capricor Therapeutics' rating was downgraded amid FDA inspection risks, regulatory uncertainty, and potential delays in ...

Biotech stocks have long enticed investors with the promise of outsized gains. Amid recent federal policy shifts, two ...

Liquidia finally launched Yutrepia after years of legal battles, but faces entrenched competition from United Therapeutics' ...

The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...

Singapore unveils tax incentives, a S$5B market fund, and simplified IPO rules to boost SGX listings amid slowing economic ...

Fact checked by Vikki Velasquez More people need better medicines, and there is a rising demand for food and sustainable ...

As part of the license agreement with Novo, Deep Apple will be eligible to receive up to $812 million in payments, as well as ...

Per Schaeffer's Senior Quantitative Analyst Rocky White, CRSP has moved up toward its 260-day moving average. More ...

The S&P 500 edged 0.1% higher on Monday, June 9, as the initiation of talks between the U.S. and China raised optimism around ...